Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I

Area of Science:

• Biochemistry
• Cardiovascular Genetics

Background:

• Paraoxonase-1 (PON1) is closely linked with high-density lipoprotein (HDL) in plasma.
• This association is hypothesized to be necessary for PON1's interaction with hydrophobic complexes.

Purpose of the Study:

• To investigate the association between Paraoxonase-1 (PON1) and high-density lipoprotein (HDL) in individuals with coronary artery disease and age-matched controls.
• To explore the influence of PON1 gene polymorphisms on HDL concentrations in health and disease.

Main Methods:

• Assessed PON1 activities and concentrations in relation to HDL-cholesterol and apolipoprotein A-I (apoA-I) levels.
• Examined the impact of PON1 gene promoter (C-107 T) and coding region (Q192R, L55M) polymorphisms on HDL parameters.
• Utilized multivariate analyses to determine independent predictors of HDL concentrations.

Main Results:

• Significant positive correlations were found between PON1 levels and HDL-cholesterol/apoA-I in both cases and controls.
• The relationship between PON1 and HDL was less effective in coronary cases compared to controls.
• The PON1 promoter polymorphism C-107 T significantly influenced HDL concentrations in controls but not in coronary cases.
• The promoter polymorphism was an independent determinant of HDL levels.

Conclusions:

• PON1 influences plasma HDL concentrations.
• Detrimental modifications in the PON1-HDL relationship are observed in individuals with coronary artery disease.
• PON1 gene promoter variations play a role in determining HDL levels, particularly in the absence of heart disease.